Optimizing Access to Monoclonal Antibodies for COVID-19 Infection: The Global Perspective

Optimizing Access to Monoclonal Antibodies for COVID-19: US PerspectiveПодробнее

Monoclonal antibodies and can they treat coronavirusПодробнее

Live Q&A: Monoclonal Antibodies Treatment for COVID-19Подробнее

COVID-19 Update: Monoclonal Antibody TreatmentПодробнее

IAVI’s Global Call to Access for Monoclonal Antibodies for COVID-19 and Other DiseasesПодробнее

Equitable Access to Monoclonal Antibody Treatmentfor COVID-19Подробнее

Monoclonal Antibody Therapy: COVID-19 TreatmentПодробнее

Monoclonal Antibodies for COVID-19 in Africa: Promise and PitfallsПодробнее

Evidence Update and Practical Perspectives: Monoclonal Antibodies for COVID-19 TreatmentПодробнее

Antibody cocktail works against Omicron | gsk says sotrovimab will neutralize omicron variantПодробнее

Challenges and opportunities on the access to future monoclonal antibodies for HIV preventionПодробнее

Monoclonal Antibodies: A Potential Treatment for #COVID19Подробнее

COVID-19 Insights: Monoclonal AntibodiesПодробнее

If You Get COVID 19: Optimize Immune System (Vitamin D, Monoclonal Antibodies, NAC, Quercetin etc.)Подробнее

Strengthening regulatory and policy frameworks to enable access to monoclonal antibodies in AfricaПодробнее

Monoclonal antibodies helping COVID-19 patientsПодробнее

Monoclonal Antibody Treatment | Successfully administered at Max Shalimar BaghПодробнее

Monoclonal Antibodies for COVID-19: Who, When, and How?Подробнее

Increasing Use of Monoclonal Antibodies Treatment of COVID 19 (Feb. 11, 2021)Подробнее